D-0078-2019 Class II Terminated

Recalled by Product Quest Manufacturing LLC — Daytona Beach, FL

FDA drug recall D-0078-2019 was initiated by Product Quest Manufacturing LLC on August 3, 2018 and is designated Class II. Reason for recall: CGMP Deviations: products manufactured under conditions that could impact its product quality. The recall status is terminated (terminated March 30, 2021). Affected quantity: Unknown.

Recall Details

Product Type
Drugs
Report Date
October 24, 2018
Initiation Date
August 3, 2018
Termination Date
March 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
Unknown

Product Description

Rexall, Extra Moisturizing No Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) 1 FL OZ (30 mL) bottle, 48 pk. (12687901)

Reason for Recall

CGMP Deviations: products manufactured under conditions that could impact its product quality.

Distribution Pattern

Nationwide in the USA

Code Information

All lots remaining within expiry.